Technology Sponsor
aCGT Vector is an international Cell Therapy GMP-in-a-POD manufacturing platform business that is working to increase patient access to precision personalized medicine by enabling a network of hospital centres of cancer excellence. Their goal is deployment of cell therapy procedures proximal to patients, eliminating logistical complexity and risk using hospital co-located manufacturing technology platforms. A next-generation hospital-based cell therapy procedure company, the core aim is to bring promise to the 350 million patients suffering from over 7,000 rare diseases around the world through delivery of procedures across its network of hospital-based GMP-in-a-POD Cell Therapy centres.
